AUXL: Analysis & Opinions

  1. Data on Auxilium's Xiaflex - Analyst Blog

    February 07, 2013
    Auxilium Pharmaceuticals, Inc. (AUXL) recently announced that data from the pivotal phase III trials, IMPRESS (The ...
  2. Repros Delays ZA-301 Study Results - Analyst Blog

    January 31, 2013
    Repros Therapeutics Inc. (RPRX) recently announced that results from the first pivotal study (ZA-301) of Androxal ...
  3. AUXL Files Patent Infringement Suit - Analyst Blog

    January 31, 2013
    Auxilium Pharmaceuticals, Inc. (AUXL) recently announced the initiation of a patent infringement lawsuit against ...
  4. Patent Challenge for Auxilium Pharma - Analyst Blog

    January 07, 2013
    Auxilium Pharmaceuticals, Inc. (AUXL) and Xstelos Holdings, Inc. (XTLS) recently received a notice from Upsher-Smith ...
  5. Standard Review for Auxilium's Drug - Analyst Blog

    December 28, 2012
    Auxilium Pharmaceuticals, Inc. (AUXL) recently announced that the FDA has accepted its supplemental Biologics ...
  6. Healthcare Stocks, Including Pharmacyclics, Making Big ...

    December 17, 2012
    On a good day for the market, the Nasdaq has risen 0.5%, the S&P 500 has increased 0.6% and the Dow has moved up ...
  7. Regeneron Pharmaceuticals and More Big Movers in ...

    December 13, 2012
    The Nasdaq has decreased 0.4%, the S&P 500 has fallen 0.3% and the Dow is down 0.2% on a bad morning for the market. ...
  8. AUXL Downgraded to Underperform - Analyst Blog

    November 19, 2012
    We recently downgraded Auxilium Pharmaceuticals, Inc. (AUXL) to Underperform with a price target of $17.00. Auxilium ...
  9. Weak Quarter from Auxilium Pharma - Analyst Blog

    November 08, 2012
    Auxilium Pharmaceuticals, Inc. (AUXL) reported a loss of 21 cents per share in the third quarter of 2012, wider than ...
  10. Neutral on Auxilium Pharma - Analyst Blog

    September 18, 2012
    We recently reiterated our Neutral recommendation on Auxilium Pharmaceuticals, Inc. (AUXL) which carries a Zacks #3 ...
  11. Update on Repros' Androxal - Analyst Blog

    September 14, 2012
    Repros Therapeutics Inc. (RPRX) recently provided an update on its phase III program, Androxal indicated for the ...
  12. Onyx Pharmaceuticals Among Healthcare's Biggest Movers ...

    August 21, 2012
    The Nasdaq has moved little, the S&P 500 has moved up 0.3% and the Dow has climbed 0.2% after the morning's trading. ...
  13. A Profitable Quarter for Auxilium - Analyst Blog

    August 02, 2012
    Auxilium Pharmaceuticals, Inc. (AUXL) swung to a profit in the second quarter of 2012 with earnings coming in at 16 ...
  14. Biggest Healthcare Sector Movers, Including SHPG

    July 31, 2012
    After the morning's trading, the Nasdaq is trading up 0.4%, the S&P 500 remains relatively unchanged and the Dow is ...
  15. 2Q Revenues Decline at Actelion - Analyst Blog

    July 20, 2012
    Switzerland-based Actelion (ALIOF) reported second quarter 2012 earnings of $1.56 per American Depository Receipt ...
  16. Job Cuts Expected at Actelion - Analyst Blog

    July 12, 2012
    Switzerland-based Actelion (ALIOF) recently announced that approximately 135 employees of the company could be shown ...
  17. Canada Approves Auxilium's Xiaflex - Analyst Blog

    July 10, 2012
    Auxilium Pharmaceuticals, Inc.'s (AUXL) Xiaflex recently gained approval in yet another country. Auxilium Pharma and ...
  18. 3 Stocks Ripe for Upside Reversals

    July 23, 2011
    Sentiment seems to be turning more favorable toward these three stocks, and given new insider buying, shares may be ...
Marketplace
Trading Center